Msd Partners, L.P. Oragenics Inc Transaction History

Msd Partners, L.P.

  • $939 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$0.78 - $3.57 $33,196 - $151,935
-42,559 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$1.16 - $2.0 $49,368 - $85,118
42,559 New
42,559 $59,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $36.1M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Msd Partners, L.P. Portfolio

Follow Msd Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Msd Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email